PCP Capital Partners LLP v Barclays Bank Plc

JurisdictionEngland & Wales
JudgeMr Justice Waksman
Judgment Date26 February 2021
Neutral Citation[2021] EWHC 307 (Comm)
Date26 February 2021
Docket NumberClaim No. CL-2016-000049
CourtQueen's Bench Division (Commercial Court)

[2021] EWHC 307 (Comm)

IN THE HIGH COURT OF JUSTICE

BUSINESS AND PROPERTY COURTS

OF ENGLAND AND WALES

COMMERCIAL COURT (QBD)

Before:

THE HONOURABLE Mr Justice Waksman

Claim No. CL-2016-000049

Between:
(1) PCP Capital Partners LLP
(2) PCP International Finance Limited
Claimants
and
Barclays Bank Plc
Defendant

Joe Smouha QC, James Collins QC, Robert Weekes and Owen Lloyd by (instructed by Quinn Emanuel Urquhart and Sullivan UK LLP, Solicitors) for the Claimants

Jeffery Onions QC, David Quest QC, Charlotte Eborall, Alexander Polley and Oliver Butler (instructed by Simmons & Simmons LLP, Solicitors) for the Defendant

Hearing dates: 8–12, 15–17, 19 and 22–24 June, 2, 6–10, 13–16, 20–24, 27–28 and 31 July, 3–7 August and 12–16 and 19 October 2020

TABLE OF CONTENTS

PART ONE — GENERAL

BETWEEN

1

Claimants

1

Defendant

1

GENERAL INTRODUCTION

6

The Parties

6

The Capital Raise of October-November 2008

6

PCP's claim against Barclays

8

THE CRIMINAL AND FCA PROCEEDINGS

11

THE INSTRUMENTS

12

CHRONOLOGICAL OVERVIEW

13

Introduction to Overview

13

Before October 2008

13

October 2008

15

November 2008

27

2009

32

THE ISSUES

32

THE EVIDENCE

33

Live Witnesses

33

Hearsay Notices

34

Expert Evidence

34

Particular evidential features of this case

35

SUBMISSIONS

37

SOME PRELIMINARY FACTUAL MATTERS

38

Introduction

38

The general position of Barclays

38

The role and abilities of Ms Staveley

40

The general credibility of Ms Staveley

41

Mr Jassim's business connections with Ms Staveley

42

The credibility of Barclays' witnesses including Mr Forbes

43

Adverse inferences from witnesses not called

45

The Yeltex Invoice and the events of 8 and 9 October

45

The Yeltex Invoice

45

Events of 8 and 9 October 2008

50

Some Dealings with Mr Restis

51

PART TWO — LIABILITY

INTRODUCTION TO LIABILITY ISSUES

53

THE MAKING OF THE SDR

53

23 October

54

24 October

57

31 October

58

THE MEANING OF THE SDR

59

THE MAKING OF THE JR

62

THE MAKING OF THE INVESTOR REPRESENTATION

69

PCP AS REPRESENTEE (1): INTENTION THAT REPRESENTATIONS SHOULD BE RELIED UPON BY PCP

70

Introduction

70

Analysis

71

PCP AS REPRESENTEE (2): RELIANCE BY PCP

73

FALSITY OF THE SDR (1): BY REASON OF ASA 2

75

Introduction

75

Sham — the Law

75

The parties' cases on sham

77

ASA 1 — Key Facts

78

ASA 1 — Analysis

85

Conclusion on ASA 1 as a sham

89

ASA 2 — Introduction

89

The genesis of ASA 2

90

The Text of ASA 2

92

The Benefits by then of ASA 1

93

Barclays' Perception of Future benefits under ASA 2

96

Post-Asa 2 Benefits

96

ASA 2 — Analysis

97

Conclusion

100

Falsity: ASA 2 as connected to CR 2

100

FALSITY OF THE SDR (2): BY REASON OF THE £66M FEE

101

Introduction

101

Analysis

102

FALSITY OF THE SDR (3): BY REASON OF THE LOAN

104

Introduction

104

The Consideration Point

105

The Funding Point

112

Footnote: Unlawful Financial Assistance

113

THE JR — FALSITY

113

THE IR — FALSITY

113

DISHONESTY

113

The Law

113

Analysis

114

The SDRs

114

The JR

115

Generally

116

CONCLUSION ON LIABILITY

116

PART THREE — CAUSATION AND LOSS

INTRODUCTION TO CAUSATION AND LOSS

117

CENTRAL ISSUES IN CAUSATION AND LOSS

117

OVERARCHING LEGAL ISSUES

118

The Law on balance of probabilities as against loss of chance assessment

118

A more than 10% Threshold?

122

The Approach to Quantification

123

Loss of Chance as alternative to Balance of Probabilities

124

Mixed Questions

124

The “Fair Wind” Principle

124

Loss of Chance and Multiple Sequential Contingencies

125

Loss of Chance where more than one positive outcome to the contingency is a real possibility

125

ISSUE 1: IN THE COUNTERFACTUAL WORLD, WOULD BARCLAYS HAVE DEALT WITH PCP AT ALL?

126

ISSUE 2: HAD THE REPRESENTATIONS NOT BEEN MADE, WHAT WOULD PCP HAVE DISCOVERED?

126

ISSUE 3: IN THE COUNTERFACTUAL WORLD, WOULD PCP HAVE OBTAINED ADDITIONAL VALUE FROM BARCLAYS AND IF SO, WHAT?

129

PCP's pleaded case

129

Barclays' Preliminary Objection

130

Interrelation between Issue 3 and Issue 5

131

The Scenarios now pursued by PCP

131

Implications of the Balance of Probabilities Assessment on Issue 3

132

The Evidence

133

Conclusion on Issue 3

136

ISSUE 4: IN THE COUNTERFACTUAL WORLD, WOULD PCP HAVE OBTAINED ADDITIONAL TIME FROM BARCLAYS AND IF SO, HOW MUCH?

136

Introduction

136

Original AT

137

Later AT

138

ISSUE 5: WHATEVER BARCLAYS WOULD HAVE BEEN PREPARED TO GIVE BY WAY OF AV AND/OR AT, WOULD OTHER SHAREHOLDERS (WHOSE CONSENT WAS NECESSARY AT AN EGM) HAVE AGREED WITH THE REQUISITE MAJORITY OF 75%?

139

ISSUE 6: IN THE COUNTERFACTUAL WORLD, WOULD SHEIKH MANSOUR AND/OR IPIC HAVE BEEN PREPARED TO INVEST THROUGH PCP I.E WITH PCP MAINTAINING CONTROL OF THE SPVS AT COMPLETION?

140

Introduction

140

Why did PCP lose control?

140

The Counterfactual Position

144

ISSUE 7: WHAT REMUNERATION WOULD PCP HAVE AGREED WITH SHEIKH MANSOUR AND/OR IPIC IN THE COUNTERFACTUAL WORLD?

145

Introduction

145

Remuneration Basis 1

145

The Remuneration Agreement allegedly made: PCP's case

145

The Remuneration Agreement allegedly made: Barclays' case

146

The Majlis Agreement

147

The Emergence of the Heads of Terms

151

The 18 November Agreement

153

The Uncommerciality Argument

156

Introduction

156

The Meaning of the Terms

156

The Uncommerciality Points in detail

157

Conclusion on Remuneration Basis 1

162

Remuneration Basis 2

162

Remuneration Basis 3

162

Remuneration Basis 4

163

Conclusion on Issue 7

163

ISSUE 8: WOULD PCP HAVE BEEN ABLE TO RAISE THE DEBT FINANCE REQUIRED AND IF SO, HOW MUCH?

163

Introduction

163

The Bank Disclosure

164

The Witness Statements of Ms Staveley and Mr Attieh on DB Debt Finance

165

The Nature of the Issue 8 Exercise

166

The Experts

166

The Debt Financing Position in the Real World

168

GSI

168

JPM

169

The Counterfactual (1): Non-recourse financing in relation to the MCNs

174

Introduction to Mr Srinivasan's Model

174

A Block Sale in Principle?

175

Availability of borrow shares to effect the block trade

178

The Size of the Block Discount

179

Profitability for DB

183

Other Points

186

The Counterfactual (2): RCI Financing

187

Introduction

187

Real World information on any RCI Financing

187

RCI Financing in the Counterfactual

189

The Counterfactual (3): The impact of any AT

191

Conclusion

193

ISSUE 9: WOULD PCP HAVE BEEN ABLE TO RAISE SUFFICIENT FUNDS OVERALL FOR THE SUBSCRIPTION? (“THE FUNDING SUFFICIENCY ISSUE”)

193

Introduction

193

The Other Investors Issue

193

Relevance

193

Substance

194

The Shortfall Issue

197

Introduction

197

Use of Warrants

198

Use of AV

199

Conclusions on the Shortfall Issue

200

The Sale of the RCIs Issue

200

Conclusion on Issue 9

200

ISSUES 8 AND 9 TAKEN TOGETHER

201

ISSUE 6 REVISITED

201

PCP'S RESIDUAL CASE ON LOSS

203

Remuneration Basis 4

203

Remuneration Basis 2

205

A Final Alternative

205

CONCLUSIONS ON CAUSATION AND LOSS

205

ISSUE 10: WHAT, IF ANY, LOSS HAS PCP SUFFERED IN THE LIGHT OF THE FOREGOING?

205

Introduction

205

The Assumptions

207

Assumption 4: Split of the warrants

207

Assumption 5 (a): Definition of “profit” for Remuneration Basis 1 and Assumption 5 (c): Definition of “carried interest” for Remuneration Basis 3

207

Assumption 6: RCI Exit Date

207

Assumption 7: Amount of Block Discount share price

207

Assumption 8: Cap on additional fees

208

Assumption 9: Amount and terms of MCN debt financing

208

Assumption 11: Treatment of £30m cash fee received by PCP in April 2009

209

Assumption 12: Treatment of costs associated with the collar financing

209

Assumption 13: Ongoing cost of RCI loan

209

Assumption 15(a): Volatility assumption to arrive at the Theoretical Value of warrants and Assumption 15 (b): Volatility assumption to arrive at the Realisable value of warrants

210

Assumption 16: Availability of MCN Commissions to contribute to the funding of the Subscription Amount

210

Assumption 17: Exercising or unwinding the collar financing arrangement

210

Assumption 20: Ex-post discount on Warrants' realisable value

211

Assumption 21: Date of conversion of MCN to Barclays shares

211

Assumption 23: Application of the Capital Preference term at the global vs fund level

211

Assumption 24.1: The source and sequence of funding for subscribing to the Instruments for...

To continue reading

Request your trial
5 cases
  • Centenary 6 Limited Against Tlt Llp
    • United Kingdom
    • Court of Session
    • 5 May 2023
    ...Liability, para 11-280, McGregor para 10-52, Thomas v Albutt [2015] PNLR 29, PCP Capital Partners LLP v Barclays Bank Plc [2021] EWHC 307 (Comm) at paras [559]-[561]). [30] The issue for the court was whether the factors which would have had a bearing on the prospects of success were truly ......
  • TMO Renewables Ltd ((in Liquidation)) v Timothy Stephen Kenneth Yeo
    • United Kingdom
    • Chancery Division
    • 20 July 2021
    ...evidence at trial is consistent or inconsistent with the documents, bearing in mind also that (as Waksman J said in PCP Capital Partners LLP v Barclays Bank Plc [2021] EWHC 307 (Comm) at [142]) some witnesses may, for whatever reason, have better (or less fallible) recollections than other......
  • BASF Corporation v Carpmaels and Ransford (A Firm)
    • United Kingdom
    • Chancery Division
    • 29 October 2021
    ...were agreed that it must be at least a 10% chance to represent a real lost opportunity: see the summary in PCP Capital v Barclays [2021] EWHC 307 (Comm), at [554]–[561], per Waksman 337 I do not however see that the same analysis can sensibly be applied to the claim in respect of the lost ......
  • Amanda Louise Staveley v Victor Restis
    • United Kingdom
    • Chancery Division
    • 25 March 2024
    ...and the Note. Mr Loveday sought to persuade me that her evidence was credible and relied on the comments of Waksman J in PCP Capital Partners LLP v Barclays Bank plc [2021] EWHC 307 Comm at paragraphs 164–170. What he did not show me, which I can only assume was an oversight on his part, w......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT